After a patient successfully completes his or her treatment for cancer, elation is often followed by the fear of recurrence. That is why we encourage all physicians involved in those patients’ care to speak with them about the need for consistent... Read More
OHC’s gynecologic oncology surgeons, Marcia Bowling, M.D. and Nancy Simon, M.D. are regional leaders in the use of the da Vinci Surgery System on women with gynecologic cancers. The da Vinci System allows for a high degree of precision, and... Read More
OHC participated in the clinical trial titled, “A Single-Arm, Open-Label, Expanded Access Study of RO5185426 in Patients with Metastatic Melanoma.” The purpose of this clinical trial was to allow access to this study drug to patients in which... Read More
OHC participated in the clinical trial titled, “A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based... Read More
